Athersys Inc (ATHXQ)

[stocktrademan]

$ATHX recent news/filings

bullish
oversold

## source: finance.yahoo.com

Fri, 17 Apr 2015 14:46:00 GMT ~ ATHERSYS, INC / NEW Files SEC form 8-K, Other Events, Financial Statements and Exhibits


read full: http://biz.yahoo.com/e/150417/athx8-k.html
*********************************************************

Fri, 17 Apr 2015 14:25:08 GMT ~ Athersys stroke treatment fails study, shares slide

[Reuters] - Athersys Inc's stem-cell therapy, its only product to reach human trials, failed a mid-stage study testing it as a treatment for a type of stroke, wiping off more than 40 percent of the company's market value. Data showed on Friday that patients given the therapy, MultiStem, did not show a significant difference from those given a placebo as measured by the Global Stroke Recovery Assessment scale. The study, which was to test the safety and efficacy of the treatment given between 24 and 48 hours after an ischemic stroke, showed that MultiStem was not better than a placebo when given after 36 hours, the company said. "Unfortunately, we just didn't have the window right for this study... We believe, investors should see this as a sign that MultiStem works," Athersys Chief Operating Officer William Lehmann told Reuters.

read full: http://finance.yahoo.com/news/athersys-stroke-treatment-fails-study-103248286.html
*********************************************************

Fri, 17 Apr 2015 10:31:47 GMT ~ Athersys Announces Results From Phase 2 Study of MultiStem(R) Cell Therapy for Treatment of Ischemic Stroke

[at noodls] - CLEVELAND, April 17, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced interim results from its exploratory Phase 2 clinical study of the intravenous administration of MultiStem® cell ...

read full: http://www.noodls.com/view/4D1474AA18F62C2EDEBE4F69B754B8977BF1C365
*********************************************************

Fri, 17 Apr 2015 10:12:00 GMT ~ Athersys stroke treatment fails mid-stage study

[Reuters] - Drug developer Athersys Inc said its experimental cell therapy did not meet the primary and secondary endpoints of a study testing it as a treatment for a type of stroke. Data from the mid-stage study ...

read full: http://finance.yahoo.com/news/athersys-stroke-treatment-fails-mid-101200693.html
*********************************************************

Fri, 17 Apr 2015 10:00:00 GMT ~ Athersys Announces Results From Phase 2 Study of MultiStem(R) Cell Therapy for Treatment of Ischemic Stroke

[GlobeNewswire] - CLEVELAND -- Athersys, Inc. today announced interim results from its exploratory Phase 2 clinical study of the intravenous administration of MultiStem(R) cell therapy to treat patients who have suffered ...

read full: http://finance.yahoo.com/news/athersys-announces-results-phase-2-100000147.html
*********************************************************

$ATHX charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$ATHX company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ATHX/company-info
Ticker: $ATHX
OTC Market Place: Not Available
CIK code: 0001368148
Company name: Athersys, Inc.
Incorporated In: DE, USA

Business Description:

$ATHX share structure

## source: otcmarkets.com

Market Value: $174,914,770 a/o Apr 16, 2015
Shares Outstanding: 80,236,133 a/o Mar 09, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001

$ATHX extra dd links

Company name: Athersys, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ATHX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ATHX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ATHX+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ATHX/news - http://finance.yahoo.com/q/h?s=ATHX+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ATHX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ATHX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ATHX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ATHX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Athersys%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Athersys%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Athersys%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ATHX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001368148&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ATHX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ATHX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ATHX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ATHX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ATHX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ATHX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ATHX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ATHX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ATHX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ATHX+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ATHX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ATHX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ATHX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ATHX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ATHX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ATHX/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ATHX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ATHX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ATHX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ATHX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ATHX



$ATHX DD Notes ~ http://www.ddnotesmaker.com/ATHX